In both studies , olodaterol @ g and @ g significantly improved the FEV@ AUC@-@ response ( P < @ ) and trough FEV@ ( study @ , P < @ ; study @ , P < @ , post hoc ) at week @ , with an incidence of adverse events comparable with that of placebo .